Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James N Butera

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|February 14, 2018
Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual DiseaseThomas A Ollila, Adam J Olszewski, James N Butera, et al.
Leukemia & Lymphoma|October 29, 2009
Epstein-Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphomaDomingo Morales, Brady Beltran, Fernando Hurtado De Mendoza, et al.
Rhode Island Medical Journal (2013)|June 3, 2020
Intrahepatic Cholangiocarcinoma in a Patient with Hepatitis C: A Cautionary TaleSoumitri Barua, Sophie Sprecht-Walsh, Zoe Weiss, et al.
The Oncologist|February 20, 2010
Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphomaJorge J Castillo, Eric S Winer, Dariusz Stachurski, et al.
Clinical Nephrology. Case Studies|October 19, 2017
Cryoglobulinemic membranoproliferative glomerulonephritis associated with mucosa-associated lymphoid tissue lymphoma treated with rituximabAustin Y Ha, Nicole Noronha, Patrick Gleason, et al.
Leukemia & Lymphoma|October 6, 2010
Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphomaJorge J Castillo, Eric S Winer, Dariusz Stachurski, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 18, 2011
HIV-negative plasmablastic lymphoma: not in the mouthJorge J Castillo, Eric S Winer, Dariusz Stachurski, et al.
Cancer Chemotherapy and Pharmacology|July 16, 2011
Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHLJohn L Reagan, Alan Rosmarin, James N Butera, et al.
American Journal of Respiratory and Critical Care Medicine|July 27, 2019
Systemic Amyloidosis Mimicking Lung CancerAdam S Fisch, Florian J Fintelmann, Maria L Garcia-Moliner, et al.
Journal of Translational Medicine|June 21, 2013
Cellular immunotherapy for refractory hematological malignanciesJohn L Reagan, Loren D Fast, Howard Safran, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Clinical Lymphoma, Myeloma & Leukemia|February 14, 2018
Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual DiseaseThomas A Ollila, Adam J Olszewski, James N Butera, et al.
Leukemia & Lymphoma|October 29, 2009
Epstein-Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphomaDomingo Morales, Brady Beltran, Fernando Hurtado De Mendoza, et al.
Rhode Island Medical Journal (2013)|June 3, 2020
Intrahepatic Cholangiocarcinoma in a Patient with Hepatitis C: A Cautionary TaleSoumitri Barua, Sophie Sprecht-Walsh, Zoe Weiss, et al.
The Oncologist|February 20, 2010
Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphomaJorge J Castillo, Eric S Winer, Dariusz Stachurski, et al.
Clinical Nephrology. Case Studies|October 19, 2017
Cryoglobulinemic membranoproliferative glomerulonephritis associated with mucosa-associated lymphoid tissue lymphoma treated with rituximabAustin Y Ha, Nicole Noronha, Patrick Gleason, et al.
Leukemia & Lymphoma|October 6, 2010
Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphomaJorge J Castillo, Eric S Winer, Dariusz Stachurski, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 18, 2011
HIV-negative plasmablastic lymphoma: not in the mouthJorge J Castillo, Eric S Winer, Dariusz Stachurski, et al.
Cancer Chemotherapy and Pharmacology|July 16, 2011
Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHLJohn L Reagan, Alan Rosmarin, James N Butera, et al.
American Journal of Respiratory and Critical Care Medicine|July 27, 2019
Systemic Amyloidosis Mimicking Lung CancerAdam S Fisch, Florian J Fintelmann, Maria L Garcia-Moliner, et al.
Journal of Translational Medicine|June 21, 2013
Cellular immunotherapy for refractory hematological malignanciesJohn L Reagan, Loren D Fast, Howard Safran, et al.
Pageof 4